Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1623 1626 1629 1691
This examiner grants 78% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18869126 | NOVEL HEPATOSELECTIVE POLYADENYLATING POLYMERASES INHIBITORS AND THEIR METHOD OF USE | Non-Final OA | The University of North Carolina at Chapel Hill |
| 18555154 | RETINOL FORMULATION (III) | Non-Final OA | DSM IP ASSETS B.V. |
| 18938730 | IMIDAZOPIPERAZINE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS | Non-Final OA | Board of Regents, The University of Texas System |
| 17636511 | PHARMACEUTICAL FORMULATIONS OF TENOFOVIR ALAFENAMIDE | Non-Final OA | Gilead Sciences, Inc. |
| 18795621 | DERIVATIVES OF SOBETIROME | Non-Final OA | OREGON HEALTH & SCIENCE UNIVERSITY |
| 18938453 | MODULATORS OF TREX1 | Non-Final OA | Constellation Pharmaceuticals, Inc. |
| 18849279 | COMPOSITIONS FOR AND METHODS OF MODULATING RNA STABILITY | Non-Final OA | Duke University |
| 18937105 | CARBAMOYL PHENYLALANINOL COMPOUNDS AND USES THEREOF | Non-Final OA | AXSOME MALTA LTD. |
| 18920063 | ORGANIC COMPOUND SALTS | Non-Final OA | GH RESEARCH IRELAND LIMITED |
| 18781180 | CRYSTALLINE BIS-MIPROCIN FUMARATE | Non-Final OA | CAAMTECH, INC. |
| 18821660 | USE OF NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS FOR IMMUNOTHERAPY IN MELANOMA PATIENTS | Non-Final OA | Chapman University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy